Quantum BioPharma Ltd (NASDAQ:QNTM) shares, rose in value on Friday, June 20, with the stock price up by 15.97% to the previous day’s close as strong demand from buyers drove the stock to $35.00.
Actively observing the price movement in the last trading, the stock closed the session at $30.18. Referring to stock’s 52-week performance, its high was $31.60, and the low was $2.70. On the whole, QNTM has fluctuated by 207.29% over the past month.
With the market capitalization of Quantum BioPharma Ltd currently standing at about $94.85 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-14.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that QNTM’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of QNTM currently trading nearly 103.67% and 199.97% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 91.11, while the 7-day volatility ratio is showing 4.13% which for the 30-day chart, stands at 8.36%. Furthermore, Quantum BioPharma Ltd (QNTM)’s beta value is 0.52, and its average true range (ATR) is 2.95.
A comparison of Quantum BioPharma Ltd (QNTM) with its peers suggests the former has fared considerably weaker in the market. QNTM showed an intraday change of 15.97% in last session, and over the past year, it grew by 156.53%%.
Data on historical trading for Quantum BioPharma Ltd (NASDAQ:QNTM) indicates that the trading volumes over the past 3 months, they’ve averaged 473.06K. According to company’s latest data on outstanding shares, there are 2.71 million shares outstanding.
Quantum BioPharma Ltd’s shares belong to company insiders and institutional investors own 2.58% of the company’s shares. The stock has risen by 851.09% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the QNTM stock heading into the next quarter.
